Radioimmunotherapy: Is avidin-biotin pretargeting the preferred choice among pretargeting methods?

被引:0
作者
David M. Goldenberg
Chien-Hsing Chang
Robert M. Sharkey
Edmund A. Rossi
Habibe Karacay
William McBride
Hans J. Hansen
Jean-Francois Chatal
Jacques Barbet
机构
[1] Garden State Cancer Center,Center for Molecular Medicine and Immunology
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2003年 / 30卷
关键词
Effector Molecule; Bispecific Antibody; Brain Tumor Therapy; Engineer Fusion Protein; Chemical Construct;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:777 / 780
页数:3
相关论文
empty
未找到相关数据